IS7422A - Efni með viðloðunareiginleika - Google Patents

Efni með viðloðunareiginleika

Info

Publication number
IS7422A
IS7422A IS7422A IS7422A IS7422A IS 7422 A IS7422 A IS 7422A IS 7422 A IS7422 A IS 7422A IS 7422 A IS7422 A IS 7422A IS 7422 A IS7422 A IS 7422A
Authority
IS
Iceland
Prior art keywords
adhesive properties
adhesive
properties
Prior art date
Application number
IS7422A
Other languages
English (en)
Inventor
Gizurarson Sveinbjörn
Original Assignee
Lyfjathroun Hf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyfjathroun Hf. filed Critical Lyfjathroun Hf.
Publication of IS7422A publication Critical patent/IS7422A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7422A 2002-02-25 2004-08-24 Efni með viðloðunareiginleika IS7422A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS6283 2002-02-25
IS6453 2002-07-03
PCT/IS2003/000009 WO2003070273A1 (en) 2002-02-25 2003-02-24 A bioadhesive agent

Publications (1)

Publication Number Publication Date
IS7422A true IS7422A (is) 2004-08-24

Family

ID=36763295

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7421A IS7421A (is) 2002-02-25 2004-08-24 Frásogshvati
IS7422A IS7422A (is) 2002-02-25 2004-08-24 Efni með viðloðunareiginleika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IS7421A IS7421A (is) 2002-02-25 2004-08-24 Frásogshvati

Country Status (11)

Country Link
US (2) US20050106122A1 (is)
EP (2) EP1521599A2 (is)
JP (1) JP2005519075A (is)
KR (1) KR20040095232A (is)
CN (1) CN1642576A (is)
AU (2) AU2003215885B2 (is)
BR (1) BR0307913A (is)
CA (1) CA2477321A1 (is)
IS (2) IS7421A (is)
NZ (1) NZ534738A (is)
WO (2) WO2003070273A1 (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005519075A (ja) * 2002-02-25 2005-06-30 リフジャスロウン エイチエフ 吸収促進剤
EP1765300A2 (en) * 2004-06-10 2007-03-28 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
TW200824693A (en) 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
BRPI0622061B8 (pt) * 2006-10-23 2021-05-25 Ecolab Inc composição viricida, uso e produto compreendendo a mesma
US8431692B2 (en) * 2008-06-06 2013-04-30 Quark Pharmaceuticals, Inc. Compositions and methods for treatment of ear disorders
KR20110056516A (ko) 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 점막 또는 피부를 통한 치료제의 흡수 개선
EP2512231B1 (en) 2009-12-16 2016-12-07 Ecolab Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
WO2017221275A1 (en) 2016-06-20 2017-12-28 Capretto Ehf. Thermostable formulation of biologically active substances
JP7749169B2 (ja) * 2019-06-07 2025-10-06 クヴァトリス セラピューティクス， インコーポレイテッド 中枢神経系障害を処置するための組成物および方法
MX2024011673A (es) * 2022-03-25 2024-09-27 Neurelis Inc Formulaciones intranasales de olanzapina y metodos para su uso.

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225706C2 (de) * 1982-07-09 1984-04-26 A. Nattermann & Cie GmbH, 5000 Köln Flüssige Wirkstofformulierungen in Form von Konzentraten für Mikroemulsionen
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
EP0351651B1 (en) * 1988-07-21 1993-09-15 F. Hoffmann-La Roche Ag Insulin preparation
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
CA2083553A1 (en) * 1991-11-25 1993-05-26 Kuniharu Seki Immunogen composition
US5314685A (en) * 1992-05-11 1994-05-24 Agouron Pharmaceuticals, Inc. Anhydrous formulations for administering lipophilic agents
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
GB9320597D0 (en) * 1993-10-06 1993-11-24 Proteus Molecular Design Improvements in and realting to vaccines
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
SE9602280D0 (sv) * 1996-06-10 1996-06-10 Pharmatrix Ab Immunstimulerande lipidformulering
IS4516A (is) * 1997-07-01 1999-01-02 Gizurarson Sveinbjörn Nýtt lyfjaform
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
DE19756164A1 (de) * 1997-12-17 1999-06-24 Km Europa Metal Ag Verfahren zur Herstellung eines Kokillenkörpers und Kokillenkörper
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
ES2234324T3 (es) * 1998-11-02 2005-06-16 MERCK & CO., INC. Combinaciones de un agonista 5ht1b/1d y un inhibidor selectivo de cox-2 para el tratamiento de la migraña.
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20030104048A1 (en) * 1999-02-26 2003-06-05 Lipocine, Inc. Pharmaceutical dosage forms for highly hydrophilic materials
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US20030235595A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US6468559B1 (en) * 2000-04-28 2002-10-22 Lipocine, Inc. Enteric coated formulation of bishosphonic acid compounds and associated therapeutic methods
US6495596B1 (en) * 2001-03-23 2002-12-17 Biozibe Laboratories, Inc. Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2
AU2002333194B2 (en) * 2001-08-16 2006-05-04 Lyfjathroun H.F., Biopharmaceuticals A method of producing antibodies ex-vivo
WO2003053400A1 (en) * 2001-12-19 2003-07-03 Alza Corporation Formulation & dosage form for the controlled delivery of therapeutic agents
CA2470826A1 (en) * 2001-12-20 2003-07-03 Bristol-Myers Squibb Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
JP2005519075A (ja) * 2002-02-25 2005-06-30 リフジャスロウン エイチエフ 吸収促進剤
WO2003070272A1 (en) * 2002-02-25 2003-08-28 Lyfjathroun Hf, Biopharmaceutical Research An immunological adjuvant
EP1509209A1 (en) * 2002-05-23 2005-03-02 UMD, Inc. Compositions and method for transmucosal drug delivery and cryoprotection
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent

Also Published As

Publication number Publication date
NZ534738A (en) 2007-01-26
AU2003215885A1 (en) 2003-09-09
WO2003070280A3 (en) 2004-05-13
AU2003215884A1 (en) 2003-09-09
BR0307913A (pt) 2005-01-11
EP1480673A1 (en) 2004-12-01
WO2003070280A2 (en) 2003-08-28
KR20040095232A (ko) 2004-11-12
AU2003215885B2 (en) 2008-07-03
WO2003070273A1 (en) 2003-08-28
IS7421A (is) 2004-08-24
CN1642576A (zh) 2005-07-20
CA2477321A1 (en) 2003-08-28
US20050063940A1 (en) 2005-03-24
US20050106122A1 (en) 2005-05-19
JP2005519075A (ja) 2005-06-30
EP1521599A2 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
NO20030179L (no) Gummimateriale
DE60308982D1 (de) Elektrolichtempfindliches Material
DE602004032448D1 (de) Sic-feuerfestmaterial mit daran gebundenem siliciumnitrid
DE60301389D1 (de) Verbesserter schnittstellenklebstoff
DE60336416D1 (de) Absorbierender artikel mit elastomerischen material
EP1538005A4 (en) THERMAL RECORDING MATERIAL
DE602004025653D1 (de) Photochromisches Material
DE602004026974D1 (de) Schichtförmiges Reibungsmaterial
DE50305444D1 (de) Haftklebeartikel
DE60311192D1 (de) Bildempfangsmaterial
DE60318169D1 (de) Bahnförmiges Verbundmaterial
DE602004026505D1 (de) Reibungsmaterial
ATA10012003A (de) Schichtwerkstoff
EP1757309A4 (en) ADHESIVE MATERIAL
DE602004001917D1 (de) Reibungsmaterial
DE10193397T1 (de) Vulkanisierende Adhäsivzusammensetzung
DK1401071T3 (da) Formstoftromle
DK1523517T3 (da) Skum med klæbemiddelmateriale-bånd
IS7422A (is) Efni með viðloðunareiginleika
DE60314701D1 (de) Elektrophotographisches Material
DE60331989D1 (de) Reibungsmaterial
FI20030466L (fi) Liimausainekoostumus
FI20020317A7 (fi) Uudet tärkkelyspohjaiset liimat
DE50202991D1 (de) Hochtemperaturfestes Klebemittel
FI20010711L (fi) Muovimateriaali